Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy

Artificial Cells, Nanomedicine and Biotechnology

Volumn 43, Issue 2, 2015, Pages 93-102

  Yadav, Sachin ^a   Gupta, Swati ^a,b  

^a ISF COLLEGE OF PHARMACY   (India)

^b Apeejay Stya University   (India)

Author keywords

Cytotoxicity; Drug delivery; Folate PEG cholesterol; Targeting; Tristearin solid fat nanoemulsions

Indexed keywords

CHOLESTEROL; CYTOTOXICITY; DRUG DELIVERY; LIGANDS; MOBILE SECURITY; SCANNING ELECTRON MICROSCOPY; TUMORS;

CHEMOTHERAPEUTIC AGENTS; ENTRAPMENT EFFICIENCY; LIPID PARTICLES; MULTIDRUG RESISTANCE; NANO-EMULSIONS; SOYA PHOSPHATIDYLCHOLINE; SURFACE-MODIFIED; TARGETING;

DISEASES;

DOCETAXEL; FOLATE RECEPTOR; FOLIC ACID; MACROGOL; NANOCARRIER; PHOSPHATIDYLCHOLINE; SOLID FAT NANOEMULSION; TRISTEARIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CHOLESTEROL; DRUG CARRIER; EMULSION; LIGAND; MACROGOL DERIVATIVE; NANOPARTICLE; POLY(ETHYLENE GLYCOL)-FOLATE; TAXOID; TRIACYLGLYCEROL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER THERAPY; CELL PROLIFERATION; CELL VIABILITY; DRUG FORMULATION; DRUG POTENCY; DRUG RELEASE; DRUG SYNTHESIS; DRUG TARGETING; HELA CELL LINE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; NANOEMULSION; NANOENCAPSULATION; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SUN; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; CHEMISTRY; DRUG DEVELOPMENT; EMULSION; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; ULTRASOUND;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CHOLESTEROL; DRUG CARRIERS; DRUG DISCOVERY; EMULSIONS; FOLIC ACID; HELA CELLS; HUMANS; LIGANDS; NANOPARTICLES; PHOSPHATIDYLCHOLINES; POLYETHYLENE GLYCOLS; SONICATION; TAXOIDS; TRIGLYCERIDES;

EID: 84926307839     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2013.845569     Document Type: Article

References (22)

1. Aggarwal S, Yadav S, Gupta S. 2011. EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer. J Biomed Nanotechnol. 7: 137-138.
2. Amselem S, Yogev A, Zawoznik E, Friedman D. 1994. Emulsomes, a novel drug delivery technology. Proc Int Symp Control Rel Bioact Mater. 21: 1368-1369.
3. Amselem S, Friedman D. 1997. Solid fat nanoemulsions. United States Patent US 5662932.
4. Caliceti P, Salmaso S, Semenzato A, Bersani S, Matricardi P, Rossi F. 2003. Synthesis and physicochemical characterization of folatecyclodextrin bioconjugate for active drug delivery. Bioconjug Chem. 14: 899-908.
5. Fumoleau P, Seidman AD, Trudeau ME, Chevallier B, Ten BHWW. 1997. Docetaxel: a new active agent in the therapy of metastatic breast cancer. Expert Opin Investig Drugs. 6: 1853-1865.
6. Fry DW, White JC, Goldman ID. 1978. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem. 90: 809-815.
7. Gupta S, Dube A, Vyas SP. 2007. Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis. J Drug Target. 15: 437-444.
8. Gupta S, Vyas SP. 2007. Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting. J Drug Target. 15: 206-217.
9. Guo W, Lee T, Sudimack J, Lee RJ. 2000. Receptor-specific delivery of liposomes via folate-peg-chol. J Liposome Res. 10: 179-195.
10. Lu Y, Low PS. 2002. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev. 54: 675-693.
11. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Contr Release. 65: 271-284.
12. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65: 55-63.
13. New RRC. 1990. Introduction and preparation of liposomes. In: New RRC, Ed. Liposomes: A Practical Approach. Oxford: IRL Press, pp. 1-104.
14. Pal A, Gupta S, Jaiswal A, Dube A, Vyas SP. 2012. Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis. J Liposome Res, 22: 62-71.
15. Rojo F, Albanell J, Rovira A, Corominas JM, Manzarbeitia F. 2008. Targeted therapies in breast cancer. Semin Diagn Pathol. 25: 245-261.
16. Saul JM, Annapragada A, Natarajan JV, Bellamkonda RV. 2003. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release. 92: 49-67.
17. Vyas SP, Katare YK, Mishra V, Sihorkar V. 2000. Ligand directed macrophage targeting of amphotericin B loaded liposomes. Int J Pharm. 210: 1-14.
18. Vyas SP, Quraishi S, Gupta S, Jaganathan KS. 2005. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages. Int J Pharm. 296: 12-25.
19. Vyas SP, Subhedar R, Jain S. 2006. Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver. J Pharm Pharmacol. 58: 321-326.
20. Vyas SP, Sihorkar V, Jain S. 2007. Mannosylated liposomes for Bio-film targeting. Int J Pharm. 330: 6-13.
21. Xiang G, Wu J, Lu Y, Liu Z, Lee RJ. 2008. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int J Pharm. 356: 29-36.
22. Yuan Z, Chen D, Zhang S, Zheng Z. 2010. Preparation, characterization and evaluation of docetexal-loaded, folate conjugated PEG-liposomes. Yakugaku Zasshi. 130: 1353-1359 .